<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02371733</url>
  </required_header>
  <id_info>
    <org_study_id>Gazi University2</org_study_id>
    <nct_id>NCT02371733</nct_id>
  </id_info>
  <brief_title>Aerobic Exercise Training in Pulmonary Arterial Hypertension</brief_title>
  <official_title>Effects of Upper Extremity Aerobic Exercise Training on Functional Exercise Capacity in Patients With Pulmonary Arterial Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gazi University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gazi University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Decreased exercise capacity, peripheral muscle strength and quality of life and increased
      dyspnea and fatigue perception is prevalent in patients with pulmonary arterial hypertension.
      It was demonstrated exercise training has beneficial effects in patients with pulmonary
      arterial hypertension. However, no study investigated the effects of upper extremity aerobic
      exercise training, therefore effects of upper extremity aerobic exercise training on outcomes
      in patients with pulmonary arterial hypertension.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients were diagnosed with pulmonary arterial hypertension according to the Task Force for
      the Diagnosis and Treatment of Pulmonary Hypertension of f the European Society of Cardiology
      (ESC) and European Respiratory Society (ERS). Primary outcome measurement was exercise
      capacity, secondary outcomes were respiratory and peripheral muscle strength, physical
      activity, quality of life, fatigue, dyspnea and depression.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional exercise capacity (Oxygen consumption measurement during test)</measure>
    <time_frame>6 weeks</time_frame>
    <description>Six minute walk test (6MWT)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maximum inspiratory and expiratory muscle strength (MIP, MEP)</measure>
    <time_frame>6 weeks</time_frame>
    <description>Mouth pressure device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peripheral muscle strength</measure>
    <time_frame>6 weeks</time_frame>
    <description>Hand held dynamometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary functions</measure>
    <time_frame>6 week</time_frame>
    <description>Spirometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity</measure>
    <time_frame>6 weeks</time_frame>
    <description>Activity monitor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dyspnea</measure>
    <time_frame>6 weeks</time_frame>
    <description>Modified Borg and Modified Medical Research Council (MMRC) dyspnea scales</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>6 weeks</time_frame>
    <description>Fatigue Severity Scale (FSS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>6 weeks</time_frame>
    <description>Short Form (SF-36) Health Survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>6 weeks</time_frame>
    <description>Montgomery Asberg Depression Rating Scale (MADRS) (Turkish versions of all scales)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Pulmonary Arterial Hypertension</condition>
  <arm_group>
    <arm_group_label>Training Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intervention:Training group will receive upper extremity aerobic exercise training using arm ergometer and breathing exercises.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham: Control group will receive alternative upper extremity exercises and breathing exercises.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Upper extremity aerobic exercise training</intervention_name>
    <description>Training group will receive upper extremity aerobic exercise training using arm ergometer at 50-80% of maximal heart rate and breathing exercises.
Training will exercise with arm ergometer 3days/week, for 6 weeks with the assistance of a physiotherapist. Training workload will be undercontrol both using target heart rate and Modified Borg dyspnea scale. Training group will also perform breathing exercises 120 times/day, 7 days/week, for 6 weeks.</description>
    <arm_group_label>Training Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Alternative upper extremity exercises</intervention_name>
    <description>Control group will receive alternative upper extremity exercises and breathing exercises. Control group will perform alternative upper extremity exercises 3days/week, for 6 weeks and also breathing exercises 120 times/day, 7 days/week, for 6 weeks.
Control group will be followed-up by telephone once a week.</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinically stable

          -  Under standard medication

          -  Group 1 pulmonary arterial hypertension patients

          -  Having no exacerbation or infection

        Exclusion Criteria:

          -  Cognitive disorders

          -  Orthopedic and neurological problems

          -  Pneumonia or acute infection

          -  Stage 4 heart failure

          -  Having no comorbidity to avoid performing evaluation and training
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Burcu Camcıoğlu, MSc</last_name>
    <role>Study Chair</role>
    <affiliation>Gazi University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Meral Boşnak Güçlü, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Gazi University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Müşerrefe N Karadallı, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gazi University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gülten Aydoğdu Taçoy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gazi University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Atiye Çengel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gazi University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Meral Boşnak-Güçlü, PhD</last_name>
    <phone>+903122162600</phone>
    <phone_ext>62929</phone_ext>
    <email>bosnakmeral@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Burcu Camcıoğlu, MSc</last_name>
    <phone>+903122162600</phone>
    <phone_ext>62929</phone_ext>
    <email>burcu.camcioglu@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Gazi University</name>
      <address>
        <city>Ankara</city>
        <zip>06500</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Burcu Camcıoğlu, MSc</last_name>
      <phone>+903122162612</phone>
      <email>burcu.camcioglu@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Meral Boşnak-Güçlü, PhD</last_name>
      <phone>+903122162612</phone>
      <email>bosnakmeral@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>D'Alonzo GE, Gianotti LA, Pohil RL, Reagle RR, DuRee SL, Fuentes F, Dantzker DR. Comparison of progressive exercise performance of normal subjects and patients with primary pulmonary hypertension. Chest. 1987 Jul;92(1):57-62.</citation>
    <PMID>3109813</PMID>
  </results_reference>
  <results_reference>
    <citation>Riley MS, Pórszász J, Engelen MP, Shapiro SM, Brundage BH, Wasserman K. Responses to constant work rate bicycle ergometry exercise in primary pulmonary hypertension: the effect of inhaled nitric oxide. J Am Coll Cardiol. 2000 Aug;36(2):547-56.</citation>
    <PMID>10933371</PMID>
  </results_reference>
  <results_reference>
    <citation>Deboeck G, Niset G, Lamotte M, Vachiéry JL, Naeije R. Exercise testing in pulmonary arterial hypertension and in chronic heart failure. Eur Respir J. 2004 May;23(5):747-51.</citation>
    <PMID>15176691</PMID>
  </results_reference>
  <results_reference>
    <citation>Mereles D, Ehlken N, Kreuscher S, Ghofrani S, Hoeper MM, Halank M, Meyer FJ, Karger G, Buss J, Juenger J, Holzapfel N, Opitz C, Winkler J, Herth FF, Wilkens H, Katus HA, Olschewski H, Grünig E. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation. 2006 Oct 3;114(14):1482-9. Epub 2006 Sep 18.</citation>
    <PMID>16982941</PMID>
  </results_reference>
  <results_reference>
    <citation>McKeough ZJ, Bye PT, Alison JA. Arm exercise training in chronic obstructive pulmonary disease: a randomised controlled trial. Chron Respir Dis. 2012 Aug;9(3):153-62. doi: 10.1177/1479972312440814. Epub 2012 Mar 27.</citation>
    <PMID>22452973</PMID>
  </results_reference>
  <results_reference>
    <citation>Nyquist-Battie C, Fletcher GF, Fletcher B, Carlson JM, Castello R, Oken K. Upper-extremity exercise training in heart failure. J Cardiopulm Rehabil Prev. 2007 Jan-Feb;27(1):42-5.</citation>
    <PMID>17474643</PMID>
  </results_reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 20, 2015</study_first_submitted>
  <study_first_submitted_qc>February 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 26, 2015</study_first_posted>
  <last_update_submitted>January 12, 2018</last_update_submitted>
  <last_update_submitted_qc>January 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gazi University</investigator_affiliation>
    <investigator_full_name>Meral Boşnak Güçlü</investigator_full_name>
    <investigator_title>Assoc. Prof</investigator_title>
  </responsible_party>
  <keyword>pulmonary arterial hypertension</keyword>
  <keyword>aerobic exercise training</keyword>
  <keyword>upper extremity</keyword>
  <keyword>exercise capacity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

